Influenza virus vaccine quadrivalent - SK Chemicals

Drug Profile

Influenza virus vaccine quadrivalent - SK Chemicals

Alternative Names: Cell culture derived quadrivalent inactivated subunit influenza vaccine - SK Chemicals; NBP 607-QIV; NBP 607-quadrivalent; Quadrivalent inactivated cell culture derived influenza vaccine - SK Chemicals; Sky Cell Flu; SKYCellflu quadrivalent

Latest Information Update: 19 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SK Chemicals
  • Class Influenza virus vaccines; Subunit vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 26 Oct 2016 Adverse events and immunogenicity data from a phase III trial in Influenza virus infections presented at the IDWeek 2016
  • 01 Oct 2016 SK Chemicals initiates a phase III trial in Influenza virus infections (Prevention, In infants, In children) in South Korea (NCT03020628)
  • 13 Jul 2016 SK Chemicals and JW Shinyak agree to co-promote quadrivalent influenza virus vaccine in South Korea for Influenza virus infections (Prevention)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top